Bio Medica Laboratories Limited (NSE:BMLL)

Market Cap	1.77B
Revenue (ttm)	381.95M +195.5%
Net Income	97.95M +2,130.0%
EPS	10.67 +2,130.3%
Shares Out	12.58M
PE Ratio	13.22
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,000
Open	141.45
Previous Close	138.70
Day's Range	140.15 - 141.55
52-Week Range	101.50 - 148.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 27, 2026

About Bio Medica Laboratories

Bio Medica Laboratories Limited engages in manufacturing pharmaceutical parenteral formulations in India. It manufactures variety of products, comprising ethical drugs, generic drugs and over the-counter drugs in the form of injectables namely Liquid Injections and dry powder injections. It provides human injectables, export of injectables, veterinary injectables, contract manufacturing, quality assurance, and research and development services. The company caters to human and veterinary needs. The company was formerly known as Bio Medica Labora...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 37
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BMLL

Financial Performance

In fiscal year 2025, Bio Medica Laboratories's revenue was 381.95 million, an increase of 150.47% compared to the previous year's 152.49 million. Earnings were 97.95 million, an increase of 272.23%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 28, 2026

Data Sources Report a data error